ISRA Investigation And Remediation Pharmaceutical Manufacture, New Jersey

By on December 27, 2019

Regulatory Agency: New Jersey Department of Environmental Protection (NJDEP)– Industrial Site Remediation (ISRA) Program
Contaminants: Soil: Petroleum Hydrocarbons (Soil)
Groundwater: Volatile Organics (Groundwater)
Remediation: Excavation & Offsite Disposal (Soil)
Pump and Treat, In-Situ Chemical Oxidation (Groundwater)
Scope: Assess, Investigate & RemediateProject Summary

  • ESI conducted a Preliminary Assessment / Site Investigation (PA/SI) at the facility and identified over 16 Areas of Concern (AOCs).
  • Investigations identified contaminants in both soil and groundwater requiring remediation.
  • Soil remediation consisted of underground storage tank (UST) and impacted soil excavation and off-site disposal. Groundwater remediation is on-going and has consisted of pump-and-dispose.
  • Property is currently being redeveloped and returned to productive use.

Project Details

A major pharmaceutical manufacturer ceased operations, triggering the NJDEP ISRA Program. In accordance with the New Jersey Site Remediation Reform Act or SRRA (N.J.S.A. 58:10C-1 et seq.) the company was required to retain a New Jersey LSRP to remediate the property.

Click to read more about this project